CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

被引：0
|
作者：
Heike Israel
Lars Neeb
Uwe Reuter
机构：
[1] Charité Headache Center,Charité Universitätsmedizin Berlin, Department of Neurology
来源：
Current Pain and Headache Reports | 2018年 / 22卷
关键词：
Chronic migraine; Episodic migraine; CGRP antibody; Migraine prevention; Antibody safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine
    Israel, Heike
    Neeb, Lars
    Reuter, Uwe
    CURRENT PAIN AND HEADACHE REPORTS, 2018, 22 (05)
  • [2] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [3] Efficacy and Safety of Anti- CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, A.
    Najjar, A.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 131 - 131
  • [4] Monoclonal antibodies against CGRP for the treatment of migraine
    Alberto Choreno-Parra, Jose
    Carnalla-Cortes, Martha
    Martinez-Zuniga, Nayeli
    Guadarrama-Ortiz, Parmenides
    REVISTA MEXICANA DE NEUROCIENCIA, 2018, 19 (04): : 45 - 61
  • [5] Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
    Lovato, Andrea
    Disco, Caterina
    Frosolini, Andrea
    Monzani, Daniele
    Perini, Francesco
    MEDICINA-LITHUANIA, 2023, 59 (09):
  • [6] Changes in quality of life after discontinuation of migraine preventative treatment with CGRP(-receptor)-antibodies
    Tehart, M.
    Raffaelli, B.
    Overeem, L. H.
    Mecklenburg, J.
    Neeb, L.
    Reuter, U.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 105 - 105
  • [7] Changes in quality of life after discontinuation of migraine preventative treatment with CGRP (-receptor)-antibodies
    Tehart, M.
    Raffaelli, B.
    Overeem, L. H.
    Mecklenburg, J.
    Neeb, L.
    Reuter, U.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 156 - 156
  • [8] CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
    Hsiangkuo Yuan
    Clinton G. Lauritsen
    Eric A. Kaiser
    Stephen D. Silberstein
    BioDrugs, 2017, 31 : 487 - 501
  • [9] Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine
    Nicol, Kelly S.
    Burkett, John G.
    CURRENT PAIN AND HEADACHE REPORTS, 2025, 29 (01)
  • [10] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
12345